Moclobemide, an inhibitor of MAO-A, does not increase daytime plasma melatonin levels in normal humans. (Q54100806)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Moclobemide, an inhibitor of MAO-A, does not increase daytime plasma melatonin levels in normal humans.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2300680

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2300680

title

Moclobemide, an inhibitor of MAO-A, does not increase daytime plasma melatonin levels in normal humans. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2300680

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2300680

main subject

melatonin

0 references

author name string

Scheinin M

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2300680

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2300680

Koulu M

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2300680

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2300680

Vakkuri O

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2300680

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2300680

Vuorinen J

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2300680

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2300680

Zimmer RH

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2300680

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2300680

publication date

1 January 1990

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2300680

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2300680

published in

Progress in Neuro-Psychopharmacology & Biological Psychiatry

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2300680

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2300680

volume

14

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2300680

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2300680

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2300680

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2300680

page(s)

73-82

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2300680

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2300680

Identifiers

DOI

10.1016/0278-5846(90)90065-O

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2300680

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2300680

PubMed publication ID

2300680

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2300680

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2300680

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54100806&oldid=916172979"